JALGX | JTLGX | JALGX / JTLGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 19 years | 19 years | - |
Gain YTD | 13.328 | 13.769 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.84B | 8.84B | 100% |
Annual Yield % from dividends | 1.60 | 1.91 | 84% |
Returns for 1 year | 16.79 | 17.35 | 97% |
Returns for 3 years | -15.74 | -14.94 | 105% |
Returns for 5 years | 2.07 | 3.66 | 56% |
Returns for 10 years | 1.31 | 3.98 | 33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WFEAX | 12.59 | 0.07 | +0.56% |
Allspring International Equity A | |||
JAIGX | 44.34 | 0.05 | +0.11% |
Janus Henderson VIT Overseas Instl | |||
SBPLX | 31.93 | -0.17 | -0.53% |
ClearBridge Dividend Strategy C | |||
LOFLX | 13.90 | -0.10 | -0.71% |
Lord Abbett Focused Large Cap Value F3 | |||
FBTAX | 31.46 | -0.69 | -2.15% |
Fidelity Advisor Biotechnology A |